يعرض 1 - 10 نتائج من 51 نتيجة بحث عن '"C. Zamagni"', وقت الاستعلام: 1.96s تنقيح النتائج
  1. 1
    دورية أكاديمية
    P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial

    المؤلفون: F. Canino, M. Barbolini, U. De Giorgi, M. Dominici, L. Gianni, L. Moscetti, C. Omarini, C. Zamagni, A. Molinaro, G. Antonelli, F. Baglio, G. Martinelli, S. Natalizio, O. Ponzoni, F. Piacentini

    المصدر: Breast, Vol 68, Iss , Pp S60- (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://www.sciencedirect.com/science/article/pii/S0960977623002370Test; https://doaj.org/toc/1532-3080Test

    الوصول الحر: https://doaj.org/article/09ba33f45426470a9465398e926855f0Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer:phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis

    المؤلفون: S I, Labidi-Galy, M, Rodrigues, J L, Sandoval, J E, Kurtz, F, Heitz, A M, Mosconi, I, Romero, U, Denison, S, Nagao, I, Vergote, G, Parma, T J, Nøttrup, E, Rouleau, G, Garnier, A, El-Balat, C, Zamagni, C, Martín-Lorente, E, Pujade-Lauraine, A, Fiévet, I L, Ray-Coquard

    المصدر: Labidi-Galy, S I, Rodrigues, M, Sandoval, J L, Kurtz, J E, Heitz, F, Mosconi, A M, Romero, I, Denison, U, Nagao, S, Vergote, I, Parma, G, Nøttrup, T J, Rouleau, E, Garnier, G, El-Balat, A, Zamagni, C, Martín-Lorente, C, Pujade-Lauraine, E, Fiévet, A & Ray-Coquard, I L 2023, ' Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer : phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis ', Annals of Oncology, vol. 34, no. 2, pp. 152-162 . https://doi.org/10.1016/j.annonc.2022.11.003Test

    مصطلحات موضوعية: Ovarian Neoplasms, BRCA2 Protein, BRCA1 Protein, genotype, BRCA mutation, Antineoplastic Agents, Hematology, olaparib, Maintenance Chemotherapy, Bevacizumab, location of mutation, type of mutation, ovarian cancer, PARP inhibitor, Oncology, Mutation, Humans, Phthalazines, Female

    وصف الملف: application/pdf; Print-Electronic

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7238bd7941a935684f35290251f1a332Test
    https://curis.ku.dk/ws/files/338357926/1_s2.0_S0923753422047330_main.pdfTest


    أضف إلى المفضلة
  3. 3
    45P MITO39: Effiacy and tolerability of PLD-trabectedin in the treatment of relapsed ovarian cancer after maintenance therapy with PARP-i, a MITO observational case-control study

    المؤلفون: M. Turinetto, S. Pignata, C. Pisano, C. Zamagni, C. Cassani, P. Malaguti, A. Parisi, P. Scollo, G. Scandurra, I. Palaia, A. Ricotti, A. Bergamini, V. Tuninetti, G. Scotto, G. Valabrega

    المصدر: ESMO Open. 8:100825

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::896966d20f91f6aafe5181ac68159d40Test
    https://doi.org/10.1016/j.esmoop.2023.100825Test


    أضف إلى المفضلة
  4. 4
    36MO Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (OC): 5-year (y) progression-free survival (PFS) by molecular subgroup in the PAOLA-1/ENGOT-ov25 trial

    المؤلفون: A.J. Gonzalez Martin, J. Medioni, P. Harter, C. Cropet, S. Cinieri, U. Denison, H. Fujiwara, I.B. Vergote, A. Bologna, S. Hietanen, M.J. Rodrigues, L.C. Hanker, C. Zamagni, S. Hernando Polo, D. Bello Roufai, D. Bauerschlag, B. You, P. Hillemanns, E. Pujade-Lauraine, I.L. Ray-Coquard

    المصدر: ESMO Open. 8:100816

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::63ddb97276b1dc220896b0603260dd61Test
    https://doi.org/10.1016/j.esmoop.2023.100816Test


    أضف إلى المفضلة
  5. 5
    216MO A randomized phase II trial of metronomic oral vinorelbine plus cyclophosphamide and capecitabine (VEX) vs weekly paclitaxel (P) as first- or second-line treatment in patients (pts) with ER+/HER2- metastatic breast cancer (MBC): The METEORA-II trial (IBCSG 54-16)

    المؤلفون: E. Munzone, M.M. Regan, S. Cinieri, E. Montagna, L. Orlando, R. Shi, E. Campadelli, L. Gianni, U.F.F. De Giorgi, C. Bengala, D. Generali, E. Collova, F. Puglisi, E. Cretella, C. Zamagni, C. Chini, A. Goldhirsch, M.A. Colleoni

    المصدر: Annals of Oncology. 33:S636-S637

    مصطلحات موضوعية: Oncology, Hematology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::df3b66ac50cad424fcb20aa8c9edd1f9Test
    https://doi.org/10.1016/j.annonc.2022.07.255Test


    أضف إلى المفضلة
  6. 6
    مؤتمر
    High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm.

    المؤلفون: G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zamagni, G. Dondi, A. M. Perrone, P. De Iaco, D. Santini.

    المساهمون: G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zamagni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini.

    مصطلحات موضوعية: high grade serous carcinoma, ovarian cancer

    وصف الملف: ELETTRONICO

    العلاقة: ispartofbook:Pathologica; Congress of the Italian Society of Anatomic Pathology (SIAPEC) 2019; firstpage:256; lastpage:257; numberofpages:2; journal:PATHOLOGICA; http://hdl.handle.net/11585/894948Test

    الإتاحة: http://hdl.handle.net/11585/894948Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    مؤتمر
    PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY)

    المؤلفون: PF. Conte, B. Agostara, M. Aieta, G. Banna, E. Barbieri, M. Belfiglio, C. Boni, L. Boni, A. Brandes, S. Cascinu, L. Cavanna, G. Colucci, R. D’Amico, M. Donadio, G. Fornari, A. Frassoldati, E. Galligioni, O. Garrone, V. Gebbia, F. Grasso, GRISOLIA, Immacolata Deborah, V. Guarneri, G. Lelli, A. Molino, A. Musolino, NANNI, ORIANA, F. Piacentini, P. Pronzato, R. Vicini, C. Zamagni

    المساهمون: Conte, Pf., Agostara, B., Aieta, M., Banna, G., Barbieri, E., Belfiglio, M., Boni, C., Boni, L., Brandes, A., Cascinu, S., Cavanna, L., Colucci, G., D’Amico, R., Donadio, M., Fornari, G., Frassoldati, A., Galligioni, E., Garrone, O., Gebbia, V., Grasso, F., Grisolia, Immacolata Deborah, Guarneri, V., Lelli, G., Molino, A., Musolino, A., Nanni, Oriana, Piacentini, F., Pronzato, P., Vicini, R., Zamagni, C.

    العلاقة: ispartofbook:Tumori; AIOM 2010; volume:10; issue:1; journal:TUMORI; http://hdl.handle.net/11380/1154718Test

    الإتاحة: http://hdl.handle.net/11380/1154718Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

    المؤلفون: C. BENGALA, C. ZAMAGNI, P. PEDRAZZOLI, P. MATTEUCCI, A. BALLESTRERO, G. DA PRADA, M. MARTINO, G. ROSTI, M. DANOVA, M. BREGNI, G. JOVIC, GUARNERI, Valentina, M. MAUR, CONTE, Pierfranco

    المساهمون: C., Bengala, C., Zamagni, P., Pedrazzoli, P., Matteucci, A., Ballestrero, G., DA PRADA, M., Martino, G., Rosti, M., Danova, M., Bregni, G., Jovic, Guarneri, Valentina, M., Maur, Conte, Pierfranco

    مصطلحات موضوعية: Breast cancer, cardiac toxicity, trastuzumab, high-dose chemotherapy

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/16570045; info:eu-repo/semantics/altIdentifier/wos/WOS:000236581500012; volume:94; issue:7; firstpage:1016; lastpage:1020; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11380/303862Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-33645748115

    الإتاحة: https://doi.org/10.1038/sj.bjc.6603060Test
    http://hdl.handle.net/11380/303862Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Dynamic changes of HLA-J expression during neoadjuvant treatment in ovarian cancer

    المؤلفون: AA Martoni, C Winterhalter, M. Rosati, W Würfel, E Veltrup, P De laco, FM Würfel, Ralph M. Wirtz, C Zamagni

    المصدر: Geburtshilfe und Frauenheilkunde.

    مصطلحات موضوعية: Neoadjuvant treatment, business.industry, Cancer research, medicine, Human leukocyte antigen, Ovarian cancer, medicine.disease, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::73ca8526248ed1f23952b34be89824f4Test
    https://doi.org/10.1055/s-0040-1718199Test


    أضف إلى المفضلة
  10. 10
    HLA-J as a new predictive marker in breast cancer for neoadjuvant chemotherapy

    المؤلفون: E Veltrup, C Winterhalter, M. Rosati, Ralph M. Wirtz, AA Martoni, C Zamagni, W Würfel, FM Würfel, P De laco

    المصدر: Geburtshilfe und Frauenheilkunde.

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, Breast cancer, Predictive marker, business.industry, Internal medicine, medicine.medical_treatment, medicine, Human leukocyte antigen, medicine.disease, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::68c832de44a167aee5ac2e256c2221e2Test
    https://doi.org/10.1055/s-0040-1717881Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث